AAAAAA

   
Results: 1-7 |
Results: 7
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma
Authors: Janik, JE Miller, LL Korn, EL Stevens, D Curti, BD Smith, JW Sznol, M Conlon, KC Sharfman, W Urba, WJ Gause, BL Longo, DL
Citation: Je. Janik et al., A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma, BLOOD, 97(7), 2001, pp. 1942-1946
T-cell adoptive immunotherapy: Moving ahead by going in a circle
Authors: Sznol, M
Citation: M. Sznol, T-cell adoptive immunotherapy: Moving ahead by going in a circle, CANCER J, 6(2), 2000, pp. 61-63
High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update
Authors: Atkins, MB Kunkel, L Sznol, M Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: Long-term survival update, CA J SCI AM, 6, 2000, pp. S11-S14
Use of preferentially replicating bacteria for the treatment of cancer
Authors: Sznol, M Lin, SL Bermudes, D Zheng, LM King, I
Citation: M. Sznol et al., Use of preferentially replicating bacteria for the treatment of cancer, J CLIN INV, 105(8), 2000, pp. 1027-1030
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993
Authors: Atkins, MB Lotze, MT Dutcher, JP Fisher, RI Weiss, G Margolin, K Abrams, J Sznol, M Parkinson, D Hawkins, M Paradise, C Kunkel, L Rosenberg, SA
Citation: Mb. Atkins et al., High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993, J CL ONCOL, 17(7), 1999, pp. 2105-2116
Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine
Authors: Rosenberg, SA Yang, JC Schwartzentruber, DJ Hwu, P Marincola, FM Topalian, SL Restifo, NP Sznol, M Schwarz, SL Spiess, PJ Wunderlich, JR Seipp, CA Einhorn, JH Rogers-Freezer, L White, DE
Citation: Sa. Rosenberg et al., Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine, J IMMUNOL, 163(3), 1999, pp. 1690-1695
Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin
Authors: Miller, LL Korn, EL Stevens, DS Janik, JE Gause, BL Kopp, WC Holmlund, JT Curti, BD Sznol, M Smith, JW Urba, WJ Donegan, SE Watson, TM Longo, DL
Citation: Ll. Miller et al., Abrogation of the hematological and biological activities of the interleukin-3/granulocyte-macrophage colony-stimulating factor fusion protein PIXY321 by neutralizing anti-PIXY321 antibodies in cancer patients receiving high-dose carboplatin, BLOOD, 93(10), 1999, pp. 3250-3258
Risultati: 1-7 |